Overview
The Drug-drug Interaction of SHR3824 and SP2086
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
The purpose of the study is to investigate the potential interaction between multiple oral doses of SHR3824 and multiple oral doses of SP2086 in healthy adult volunteers.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Criteria
Inclusion Criteria:- Healthy volunteers with a body mass index (BMI, a measure of a person's weight in
relation to height) between 19 and 24 kg/m2.
Exclusion Criteria:
- History of diabetes
- History of heart failure or renal insufficiency,Urinary tract infections, or
vulvovaginal mycotic infections
- History of or current clinically significant medical illness as determined by the
Investigator
- History of clinically significant allergies, especially known hypersensitivity or
intolerance to lactose
- Known allergy to SHR3824 or SP2086 or any of the excipients of the formulation of
SHR3824 or SP2086